KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Novavax (NVAX) Long-Term Debt Issuances (2016)

Novavax has reported Long-Term Debt Issuances over the past 3 years, most recently at $325.0 million for Q3 2016.

  • Quarterly results put Long-Term Debt Issuances at $325.0 million for Q3 2016, changed N/A from a year ago — trailing twelve months through Sep 2017 was $325.0 million (down 50.0% YoY), and the annual figure for FY2025 was $42.6 million, changed.
  • Long-Term Debt Issuances for Q3 2016 was $325.0 million at Novavax, roughly flat from $325.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for NVAX hit a ceiling of $325.0 million in Q1 2016 and a floor of $100000.0 in Q1 2012.
  • Median Long-Term Debt Issuances over the past 3 years was $725000.0 (2013), compared with a mean of $108.7 million.
  • Peak annual rise in Long-Term Debt Issuances hit 709.0% in 2013, while the deepest fall reached 709.0% in 2013.
  • Novavax's Long-Term Debt Issuances stood at $550000.0 in 2012, then grew by 16.55% to $641000.0 in 2013, then surged by 50602.03% to $325.0 million in 2016.
  • The last three reported values for Long-Term Debt Issuances were $325.0 million (Q3 2016), $325.0 million (Q1 2016), and $641000.0 (Q2 2013) per Business Quant data.